TALENTs Study: Empowering Longevity Science with Nucleotide Innovation
Zhen-Ao Group has reached an important scientific milestone in healthy aging. The Group participated in the internationally recognized TALENTs Study, a multi-center, randomized, double-blind, placebo-controlled clinical trial. Leading academic institutions, including Peking University, collaborated on the study.
The TALENTs Study investigated whether targeted nutritional strategies could support biological function and vitality in aging populations. Through rigorous clinical methodology, the study helped translate aging biology into evidence-based nutritional research.
Zhen-Ao Bio-Tech’s Scientific Contribution
As a core subsidiary of Zhen-Ao Group, Dalian Zhen-Ao Bio-Tech Co., Ltd. supplied the study’s proprietary 5′-Nucleotide ingredients.
Zhen-Ao Bio-Tech produced these nucleotides through advanced precision fermentation and enzymatic extraction platforms. These platforms help ensure high purity, consistency, and traceability.
In addition, the company developed the ingredients to meet the strict quality and reproducibility requirements of human clinical research.
Within the TALENTs Study framework, researchers explored nucleotides as a novel nutritional intervention. The study focused on their potential to support cellular metabolism, cognitive function, and overall vitality during aging. These areas continue to attract growing interest in longevity and healthspan research.
Scientific Significance of the TALENTs Findings
The positive outcomes from the TALENTs Study provide meaningful human clinical evidence for nucleotide research in aging-related nutrition science.
Importantly, the study does not position nucleotides as a cure or reversal of aging. Instead, it highlights their potential role in supporting biological pathways linked to cellular function and age-related change.
These findings also reinforce an emerging view of aging. Aging is a complex, multi-system process. Therefore, targeted nutrition may help support healthy function over time when guided by rigorous scientific validation.
A Platform for Translational Longevity Science
For Zhen-Ao Group, TALENTs represents more than a single study. It reflects a broader long-term strategy. The Group aims to build a science-driven biotechnology platform centered on yeast-derived bioactives, nucleotides, and cellular nutrition.
Zhen-Ao Bio-Tech will continue to expand research collaborations with academic institutions and global partners. Through these collaborations, the company will advance translational studies in nucleotide science and yeast-based bioactives.
Furthermore, these studies will explore how such ingredients can support human health, nutrition, and longevity-focused research in a responsible way.
By integrating upstream fermentation technology, downstream functional insight, and clinical-grade evidence generation, Zhen-Ao aims to contribute to the future of healthy aging. This vision remains grounded in data, not speculation.
About Dalian Zhen-Ao Bio-Tech Co., Ltd.
Dalian Zhen-Ao Bio-Tech Co., Ltd. is a core subsidiary of Zhen-Ao Group. The company specializes in the research, development, and production of Ribonucleic Acid (RNA), 5′-Nucleotides, Yeast Extracts, and Functional Yeast Proteins.
With globally advanced fermentation and extraction platforms, Zhen-Ao Bio-Tech serves partners across the food and beverage, nutrition, pharmaceutical, and health industries.
The company delivers high-quality, science-backed ingredients that support natural health, functional nutrition, and sustainable innovation. At the same time, it maintains high international standards for quality, safety, and regulatory compliance.